Related content

Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapy

By Bellone S.   Palmieri M.   Gokden M.   Joshua J.   Roman J.J.   Pecorelli S.   Cannon M.J.   Santin A.D.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 231-240

Elsevier

Access to resources Recommend Favorite

Distinct regulatory effect of the p34SEI-1 oncoprotein on cancer metastasis in HER2/neu-positive and -negative cells

By Jung Samil   Ohk Jiyeon   Jeong Dongjun   Li Chengping   Lee Soonduck   Duan Jingjing   Kim Changjin   Lim Jong-Seok   Yang Young   Kim Keun-Il   Lee Myeong-Sok  

International Journal of Oncology, Vol. 45, Iss. 1, 2014-07 ,pp. : 189-196

Spandidos Publications

Access to resources Recommend Favorite

The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice

By Clinchy B.  

Breast Cancer Research and Treatment, Vol. 61, Iss. 3, 2000-06 ,pp. : 217-228

Springer Publishing Company

Access to resources Recommend Favorite

Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu

By Mohanty Kartik   Saha Asim   Pal Smarajit   Mallick Palash   Chatterjee Sunil   Foon Kenneth   Bhattacharya-Chatterjee Malaya  

Breast Cancer Research and Treatment, Vol. 104, Iss. 1, 2007-07 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Nordihydroguaiaretic Acid (NDGA) Inhibits the IGF-1 and c-erbB2/HER2/neu Receptors and Suppresses Growth in Breast Cancer Cells

By Youngren Jack  

Breast Cancer Research and Treatment, Vol. 94, Iss. 1, 2005-11 ,pp. : 37-46

Springer Publishing Company

Access to resources Recommend Favorite